These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29506378)

  • 1. Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder.
    Matthes F; Massari S; Bochicchio A; Schorpp K; Schilling J; Weber S; Offermann N; Desantis J; Wanker E; Carloni P; Hadian K; Tabarrini O; Rossetti G; Krauss S
    ACS Chem Neurosci; 2018 Jun; 9(6):1399-1408. PubMed ID: 29506378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.
    Krauss S; Griesche N; Jastrzebska E; Chen C; Rutschow D; Achmüller C; Dorn S; Boesch SM; Lalowski M; Wanker E; Schneider R; Schweiger S
    Nat Commun; 2013; 4():1511. PubMed ID: 23443539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
    Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
    PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
    Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
    Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.
    Sun X; Marque LO; Cordner Z; Pruitt JL; Bhat M; Li PP; Kannan G; Ladenheim EE; Moran TH; Margolis RL; Rudnicki DD
    Hum Mol Genet; 2014 Dec; 23(23):6302-17. PubMed ID: 25035419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule splicing modifiers with systemic HTT-lowering activity.
    Bhattacharyya A; Trotta CR; Narasimhan J; Wiedinger KJ; Li W; Effenberger KA; Woll MG; Jani MB; Risher N; Yeh S; Cheng Y; Sydorenko N; Moon YC; Karp GM; Weetall M; Dakka A; Gabbeta V; Naryshkin NA; Graci JD; Tripodi T; Southwell A; Hayden M; Colacino JM; Peltz SW
    Nat Commun; 2021 Dec; 12(1):7299. PubMed ID: 34911927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA toxicity induced by expanded CAG repeats in Huntington's disease.
    Martí E
    Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myricetin Reduces Toxic Level of CAG Repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs).
    Khan E; Tawani A; Mishra SK; Verma AK; Upadhyay A; Kumar M; Sandhir R; Mishra A; Kumar A
    ACS Chem Biol; 2018 Jan; 13(1):180-188. PubMed ID: 29172480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
    Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
    J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
    Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
    J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MID1 Protein: A Promising Therapeutic Target in Huntington's Disease.
    Heinz A; Schilling J; van Roon-Mom W; Krauß S
    Front Genet; 2021; 12():761714. PubMed ID: 34659371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed small molecules targeting toxic CAG repeat RNA that causes Huntington's disease (HD) and spinocerebellar ataxia (SCAs).
    Khan E; Biswas S; Mishra SK; Mishra R; Samanta S; Mishra A; Tawani A; Kumar A
    Biochimie; 2019 Aug; 163():21-32. PubMed ID: 31075282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain.
    Toneff T; Mende-Mueller L; Wu Y; Hwang SR; Bundey R; Thompson LM; Chesselet MF; Hook V
    J Neurochem; 2002 Jul; 82(1):84-92. PubMed ID: 12091468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The length of uninterrupted CAG repeats in stem regions of repeat disease associated hairpins determines the amount of short CAG oligonucleotides that are toxic to cells through RNA interference.
    Murmann AE; Patel M; Jeong SY; Bartom ET; Jennifer Morton A; Peter ME
    Cell Death Dis; 2022 Dec; 13(12):1078. PubMed ID: 36585400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stick-slip unfolding favors self-association of expanded HTT mRNA.
    O'Brien BM; Moulick R; Jiménez-Avalos G; Rajasekaran N; Kaiser CM; Woodson SA
    Nat Commun; 2024 Oct; 15(1):8738. PubMed ID: 39384800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
    de Mezer M; Wojciechowska M; Napierala M; Sobczak K; Krzyzosiak WJ
    Nucleic Acids Res; 2011 May; 39(9):3852-63. PubMed ID: 21247881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington's Disease.
    Schilling J; Broemer M; Atanassov I; Duernberger Y; Vorberg I; Dieterich C; Dagane A; Dittmar G; Wanker E; van Roon-Mom W; Winter J; Krauß S
    J Mol Biol; 2019 Apr; 431(9):1869-1877. PubMed ID: 30711541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's Disease Protein Huntingtin Associates with its own mRNA.
    Culver BP; DeClercq J; Dolgalev I; Yu MS; Ma B; Heguy A; Tanese N
    J Huntingtons Dis; 2016; 5(1):39-51. PubMed ID: 26891106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.